Mitsubishi UFJ Trust & Banking’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-128,200
Closed -$4.04M 802
2017
Q1
$4.04M Sell
128,200
-5,160
-4% -$153K 0.01% 687
2016
Q4
$3.92M Sell
133,360
-19,160
-13% -$584K 0.01% 692
2016
Q3
$4.41M Buy
152,520
+2,820
+2% +$78.6K 0.01% 681
2016
Q2
$3.88M Sell
149,700
-11,500
-7% -$305K 0.01% 687
2016
Q1
$3.99M Sell
161,200
-470
-0.3% -$12.9K 0.01% 684
2015
Q4
$5.69M Sell
161,670
-4,990
-3% -$134K 0.01% 673
2015
Q3
$3.53M Hold
166,660
0.01% 692
2015
Q2
$4.63M Sell
166,660
-14,600
-8% -$412K 0.01% 685
2015
Q1
$5.54M Sell
181,260
-20,360
-10% -$647K 0.01% 675
2014
Q4
$6.45M Sell
201,620
-36,100
-15% -$1.17M 0.02% 666
2014
Q3
$6.73M Sell
237,720
-20,100
-8% -$560K 0.02% 651
2014
Q2
$7.06M Sell
257,820
-13,550
-5% -$361K 0.02% 650
2014
Q1
$7.15M Sell
271,370
-5,800
-2% -$166K 0.02% 645
2013
Q4
$8.11M Buy
277,170
+13,000
+5% +$413K 0.02% 640
2013
Q3
$8.08M Sell
264,170
-11,430
-4% -$382K 0.02% 633
2013
Q2
$8.74M Buy
+275,600
New +$9.05M 0.02% 602

Other funds holding GHDX

Mitsubishi UFJ Trust & Banking's GHDX Position: Q2 2017 in Review

Mitsubishi UFJ Trust & Banking sold out of Genomic Health, Inc. (GHDX) in Q2 2017, closing a stake of 128,200 shares — an estimated $4.04M sold.

Mitsubishi UFJ Trust & Banking first reported a position in GHDX in Q2 2013 and held it in 16 quarters. The position peaked at $8.74M in Q2 2013. 124 funds tracked by Wall St. Rank hold GHDX as of Q2 2017.

  • Mitsubishi UFJ Trust & Banking reported no remaining Genomic Health, Inc. position as of Q2 2017 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 128,200 Genomic Health, Inc. shares in Q2 2017, an estimated $4.04M.
  • Mitsubishi UFJ Trust & Banking first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 16 quarters.
  • Mitsubishi UFJ Trust & Banking's Genomic Health, Inc. position peaked at $8.74M in Q2 2013.
  • 124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2017.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2017, filed 8 Aug 2017.